Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Byrski

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Annales Academiae Medicae Stetinensis|November 24, 2004
[Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method]Tomasz Byrski
Hereditary Cancer in Clinical Practice|April 4, 2013
Systemic treatment for hereditary cancers: a 2012 updateEvgeny N Imyanitov, Tomasz Byrski
Cancers|May 27, 2026
Prognostic Factors for Intracranial Progression in Her-2-Overexpressing Breast Cancer Patients with Brain Metastases as Primary Relapse Site-Real-Life DataAgnieszka Majewska, Tomasz Byrski, Michał Falco
Plos One|November 3, 2021
Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experienceArtur Lemiński, Krystian Kaczmarek, Tomasz Byrski, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
The diameter of metastasis in positive sentinel lymph node biopsy affects axillary tumor load in early breast cancerMichał Falco, Bartłomiej Masojć, Tomasz Byrski, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|May 2, 2015
The Conductivity and pH Values of Dispersions of Nanospheres for Targeted Drug Delivery in the Course of Forced Equilibrium DialysisWitold Musiał, Janusz Pluta, Tomasz Byrski, et al.
Oncotarget|September 15, 2016
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancersPawel Domagala, Jolanta Hybiak, Janusz Rys, et al.
Radiation Protection Dosimetry|October 17, 2017
INVESTIGATION OF SECONDARY MIXED RADIATION FIELD AROUND A MEDICAL LINEAR ACCELERATORPiotr Tulik, Monika Tulik, Maciej Maciak, et al.
Breast Cancer Research and Treatment|June 30, 2006
Direct-to-patient BRCA1 testing: the Twoj Styl experienceJacek Gronwald, Tomasz Huzarski, Tomasz Byrski, et al.
Hereditary Cancer in Clinical Practice|January 26, 2016
Prognostic factors in Polish patients with BRCA1-dependent ovarian cancerWiktor Szatkowski, Paweł Blecharz, Jerzy W Mituś, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Annales Academiae Medicae Stetinensis|November 24, 2004
[Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method]Tomasz Byrski
Hereditary Cancer in Clinical Practice|April 4, 2013
Systemic treatment for hereditary cancers: a 2012 updateEvgeny N Imyanitov, Tomasz Byrski
Cancers|May 27, 2026
Prognostic Factors for Intracranial Progression in Her-2-Overexpressing Breast Cancer Patients with Brain Metastases as Primary Relapse Site-Real-Life DataAgnieszka Majewska, Tomasz Byrski, Michał Falco
Plos One|November 3, 2021
Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experienceArtur Lemiński, Krystian Kaczmarek, Tomasz Byrski, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
The diameter of metastasis in positive sentinel lymph node biopsy affects axillary tumor load in early breast cancerMichał Falco, Bartłomiej Masojć, Tomasz Byrski, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|May 2, 2015
The Conductivity and pH Values of Dispersions of Nanospheres for Targeted Drug Delivery in the Course of Forced Equilibrium DialysisWitold Musiał, Janusz Pluta, Tomasz Byrski, et al.
Oncotarget|September 15, 2016
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancersPawel Domagala, Jolanta Hybiak, Janusz Rys, et al.
Radiation Protection Dosimetry|October 17, 2017
INVESTIGATION OF SECONDARY MIXED RADIATION FIELD AROUND A MEDICAL LINEAR ACCELERATORPiotr Tulik, Monika Tulik, Maciej Maciak, et al.
Breast Cancer Research and Treatment|June 30, 2006
Direct-to-patient BRCA1 testing: the Twoj Styl experienceJacek Gronwald, Tomasz Huzarski, Tomasz Byrski, et al.
Hereditary Cancer in Clinical Practice|January 26, 2016
Prognostic factors in Polish patients with BRCA1-dependent ovarian cancerWiktor Szatkowski, Paweł Blecharz, Jerzy W Mituś, et al.
Pageof 10